Mearin F, Lacy BE, Chang L et al. Bowel disorders. Gastroenterology 2016;150:1393–1407.
Kassinen A, Krogius-Kurikka L, Makivuokko H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007;133:24–33.
Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011;140:91–100.
Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973;14:125–132.
Coeffier M, Gloro R, Boukhettala N et al. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am J Gastroenterol 2010;105:1181–1188.
Shulman RJ, Jarrett ME, Cain KC et al. Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome. J Gastroenterol 2014;49:1467–1476.
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712–21.e4.
Spiller R, Aziz Q, Creed F et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770–1798.
Ford AC, Moayyedi P, Lacy BE et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014;109 (Suppl 1): S2–26.
Ford AC, Bercik P, Morgan DG et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013;145:1262–70.e1.
Mooney PD, Hadjivassiliou M, Sanders DS. Coeliac disease. BMJ 2014;348:g1561.
Katz KD, Rashtak S, Lahr BD et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011;106:1333–1339.
Mustalahti K, Catassi C, Reunanen A et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010;42:587–595.
Rubio-Tapia A, Ludvigsson JF, Brantner TL et al. The prevalence of celiac disease in the United States. Am J Gastroenterol 2012;107:1538–1544.
Bingley PJ, Williams AJ, Norcross AJ et al. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ 2004;328:322–323.
Sanders DS, Carter MJ, Hurlstone DP et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001;358:1504–1508.
Sanders DS, Patel D, Stephenson TJ et al. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 2003;15:407–413.
Canavan C, Card T, West J. The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study. PLoS One 2014;9:e106478.
Ford AC, Chey WD, Talley NJ et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009;169:651–658.
Mein SM, Ladabaum U. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. Aliment Pharmacol Ther 2004;19:1199–1210.
Spiegel BM, DeRosa VP, Gralnek IM et al. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 2004;126:1721–1732.
Mohseninejad L, Feenstra T, van der Horst HE et al. Targeted screening for coeliac disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information. Eur J Health Econ 2013;14:947–957.
Rubio-Tapia A, Hill ID, Kelly CP et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656–676.
Ludvigsson JF, Bai JC, Biagi F et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 2014;63:1210–1228.
Choung RS, Rubio-Tapia A, Lahr BD et al. Evidence against routine testing of patients with functional gastrointestinal disorders for celiac disease: a population-based study. Clin Gastroenterol Hepatol 2015;13:1937–1943.
Cash BD, Rubenstein JH, Young PE et al. The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls. Gastroenterology 2011;141:1187–1193.
Manning AP, Thompson WG, Heaton KW et al. Towards positive diagnosis of the irritable bowel. BMJ 1978;2:653–654.
Drossman D, Thompson W, Talley N. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterology Int 1990;3:159–172.
Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006;130:1480–1491.
Thompson WG, Longstreth GF, Drossman DA et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45 (Suppl 2): Ii43–Ii47.
Kruis W, Thieme C, Weinzierl M et al. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984;87:1–7.
Institute TOHR. Newcastle-Ottawa quality assessment scale for case-control studies [Available from http://www.ohri.ca/programs/clinical_epidemiology/nosgen.pdf (accessed on 15 May 2016).
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–1558.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–188.
Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–634.
Sterne JA, Sutton AJ, Ioannidis JP et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
Elloumi H, El Assoued Y, Ghedira I et al. Immunological profile of coeliac disease in a subgroup of patients with symptoms of irritable bowel syndrome. Tunis Med 2008;86:802–805.
Emami M, Kouhestani S, Gholamrezaei A et al. Prevalence of celiac disease in patients with irritable bowel syndrome. Govaresh 2008;13:192–197.
Jadallah KA, Khader YS. Celiac disease in patients with presumed irritable bowel syndrome: a case-finding study. World J Gastroenterol 2009;15:5321–5325.
Zwolinska-Wcislo M, Galicka-Latala D, Rozpondek P et al. Frequency of celiac disease and irritable bowel syndrome coexistance and its influence on the disease course. Przegl Lek 2009;66:126–129.
Amiriani T, Besharat S, Roshandel G et al. Should we look for celiac disease in irritable bowel syndrome? Oman Med J 2011;26:59–60.
Elitsur Y, Khoury J, Daniel K. Celiac disease rate increases in patients with irritable bowel syndrome–a community screen from West Virginia. Gastroenterology 2010;138:S309.
Balasubramanian G, Nellaiappan V, Rathinasabapathy B. How prevalent is celiac disease in IBS-D type among South Indians? Gastroenterology 2011;140:S441–S442.
Bakhshipour A, Nezam SK, Zakeri Z et al. Coeliac disease in irritable bowel syndrome (Rome III) in Southeast Iran. Arab J Gastroenterol 2012;13:24–27.
Mehdi Z, Sakineh E, Mohammad F et al. Celiac disease: serologic prevalence in patients with irritable bowel syndrome. J Res Med Sci 2012;17:839–842.
Begtrup LM, Engsbro AL, Kjeldsen J et al. A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013;11:956–62.e1.
Houshiyar A, Fouladi N, Amani F et al. Prevalence of celiac disease in patients with irritable bowel syndrome in Ardabil-Iran (2009-10). J Gorgan Univ Med Sci 2013;14:129–133.
Pandav N, Pandley V, Shah K et al. The prevalence of celiac disease in patient with irritable bowel syndrome. Indian J Gastroenterol 2013;32 (suppl 1): A29.
Respondek W, Tomasiuk R, Jarosz M et al. Is it reasonable to perform serological tests for celiac disease in patients with irritable bowel syndrome? Preglad Gastroenterol 2013;8:184–190.
Rodrigo L, Blanco I, Bobes J et al. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther 2013;15:R201.
Mahmoodi A, Jafarihaydarlo A, Yasemi M et al. Celiac disease prevalence in the patients with irritable bowel syndrome in the Ilam province; a cross sectional study from Western Iran. J Clin Diagn Res 2014;8:Gc01–Gc03.
Mooney PD, Leeds JS, Libzo N et al. Case-finding for coeliac disease in secondary care: a prospective multicentre UK study. Dig Liver Dis 2014;46:32–35.
Shayesteh AA, Hajiani E, Hashemi SJ et al. Prevalence of celiac disease in Iranian patients with irritable bowel syndrome: a cross-sectional study. J Dig Dis 2014;15:12–17.
Ahmadi B, Zaherara M. Prevalence of celiac disease in patients with irritable bowel syndrome in Kerman, Iran. J Kerman Univ Med Sci 2015;22:319–327.
Sharma H, Verma AK, Das P et al. Prevalence of celiac disease in Indian patients with irritable bowel syndrome and uninvestigated dyspepsia. J Dig Dis 2015;16:443–448.
Wang H, Zhou G, Luo L et al. Serological screening for celiac disease in adult Chinese patients with diarrhea predominant irritable bowel syndrome. Medicine 2015;94:e1779.
Sanchez-Vargas LA, Thomas-Dupont P, Torres-Aguilera M et al. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case-control study. Neurogastroenterol Motil 2016;28:994–1000.
Chey W, Nojkov B, Saad R et al. Screening for celiac sprue in patients with suspected irritable bowel syndrome: results form a prospective US multi-center trial. Gastroenterology 2007;132 (suppl 1): A147.
Hin H, Bird G, Fisher P et al. Coeliac disease in primary care: case finding study. BMJ 1999;318:164–167.
Agreus L, Svardsudd K, Tibblin G et al. Endomysium antibodies are superior to gliadin antibodies in screening for coeliac disease in patients presenting supposed functional gastrointestinal symptoms. Scand J Prim Health Care 2000;18:105–110.
Wahnschaffe U, Ullrich R, Riecken EO et al. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001;121:1329–1338.
Demarchi B, Astegiano M, Sapone N et al. Prevalence of coeliac disease in IBS patients in Turin. Gastroenterology 2002;122 (suppl 4): A193.
Shahbazkhani B, Forootan M, Merat S et al. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:231–235.
Funka K, Leja M, Bandere B et al. Low seroprevalence of celiac disease among patients with irritable bowel syndrome in Latvia. Gut 2004;53 (suppl VI): A198.
Locke GR 3rd, Murray JA, Zinsmeister AR et al. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc 2004;79:476–482.
Kennedy TM, Chalder T, McCrone P et al. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial. Health Technol Assess 2006;10:1–67.
van der Wouden EJ, Nelis GF, Vecht J. Screening for coeliac disease in patients fulfilling the Rome II criteria for irritable bowel syndrome in a secondary care hospital in The Netherlands: a prospective observational study. Gut 2007;56:444–445.
Catassi C, Kryszak D, Louis-Jacques O et al. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol 2007;102:1454–1460.
Ozdil K, Sokmen M, Ersoy O et al. Association of gluten enteropathy and irritable bowel syndrome in adult Turkish population. Dig Dis Sci 2008;53:1852–1855.
Krigel A, Turner KO, Makharia GK et al. Ethnic variations in duodenal villous atrophy consistent with celiac disease in the United States. Clin Gastroenterol Hepatol 2016;14:1105–1111.
Ramakrishna BS, Makharia GK, Chetri K et al. Prevalence of adult celiac disease in India: regional variations and associations. Am J Gastroenterol 2016;111:115–123.
Kang JY, Kang AH, Green A et al. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther 2013;38:226–245.
Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010;31:73–81.
Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology 2005;128 (4 Suppl 1): S25–S32.
Thompson WG, Heaton KW, Smyth GT et al. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000;46:78–82.
Bohn L, Storsrud S, Tornblom H et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013;108:634–641.
Carroccio A, Mansueto P, Iacono G et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol 2012;107:1898–1906.
Biesiekierski JR, Peters SL, Newnham ED et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013145 2:e1–e3.
Molina-Infante J, Carroccio A. Suspected non-celiac gluten sensitivity confirmed in few patients after gluten challenge in double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol 2016 doi:10.1016/j.cgh.2016.08.007.